Group 1 - The core stock price of Kingsray Biotechnology (01548.HK) closed at HKD 16.800 on June 10, down 1.06% from the previous trading day, with an intraday high of HKD 17.280, marking a nearly one-year high [1] - On the same day, the net capital flow showed an inflow of HKD 306.183 million and an outflow of HKD 356.299 million, resulting in a net outflow of HKD 50.115 million [1] - Kingsray Biotechnology is a significant global provider of life science research and production services, established in 2002 and listed on the Hong Kong Stock Exchange in 2015, with operations in over 100 countries and regions [1] Group 2 - The company has over 6,900 employees globally and has been cited in more than 103,600 academic journal articles reviewed by international peers [1] - Kingsray holds over 300 authorized patents and more than 900 patent applications, along with numerous trade secrets [1] - The company's mission is to use biotechnology to enhance the health of people and nature, aiming to become the most trusted biotechnology company globally [2]